New Business Alert – Altimmune Relocates HQ to Morristown NJ from Maryland
Altimmune, Inc. (NASDAQ: ALT) announced plans to relocate its corporate headquarters from Gaithersburg, Maryland, to Morristown, New Jersey, later this year as the biopharmaceutical company seeks greater access to industry talent and operational cost efficiencies. The company officially hosted its ribbon cutting ceremony November 10, 2026!
The company said the move will position its headquarters within one of the nation’s largest biopharma hubs, providing closer proximity to a deep pool of industry professionals and strengthening its ability to recruit and retain employees under its hybrid work model. Altimmune has signed a five-year lease for office space in Morristown, NJ.
Altimmune is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic disorders, and liver diseases. Its lead candidate, pemvidutide, is being evaluated in multiple indications, including metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder, and alcohol-associated liver disease.